Literature DB >> 32718708

X Ayrignac1, N Gaillard2, C Carra-Dallière2, P Labauge2.   

Abstract

Small vessel disease of the brain is commonly identified among ageing people. It causes almost 25% of strokes and is associated with cognitive impairment and dementia as well as gait difficulties. Its diagnosis is usually made on MRI in the presence of deep white matter and basal ganglia hyperintensities as well as deep lacunar infarcts (lacunes), microbleeds and enlarged perivascular spaces. MRI is also of importance to identify the main differential diagnoses including inflammatory disorders, cerebral amyloid angiopathy and other genetic causes of microangiopathy. Small vessel disease is associated with the main vascular risk factors including notably age and hypertension but whether controlling these vascular risk factors is beneficial is still not clear. Here, we provide a comprehensive review underlining the main diagnostic features of cerebral microangiopathy and summarise the main therapeutic approaches (notably blood pressure normalisation and physical activity) used to control its development and prevent strokes as well as the development of cognitive involvement and gait impairment.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Diagnosis; Diagnostic; Diagnostic différentiel; Differential diagnosis; Microangiopathie cérébrale; Small vessel disease of the brain; Traitement; Treatment

Year:  2020        PMID: 32718708     DOI: 10.1016/j.revmed.2020.04.018

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

1.  Diagnostic Value of Image Features of Magnetic Resonance Imaging in Intracranial Hemorrhage and Cerebral Infarction.

Authors:  Wencai Tang; Fangyi Zeng; Guangtang Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-07-12       Impact factor: 3.009

2.  Traumatic Brain Magnetic Resonance Imaging Feature Extraction Based on Variable Model Algorithm in Stroke Examination.

Authors:  Zhenghong Wu; Dongqiu Wu; Weiwei Yang; Bing Wan; Sibin Liu
Journal:  Contrast Media Mol Imaging       Date:  2022-05-30       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.